药品注册申请号:085788
申请类型:ANDA (仿制药申请)
申请人:SANDOZ
申请人全名:SANDOZ INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TRIFLUOPERAZINE HYDROCHLORIDE TRIFLUOPERAZINE HYDROCHLORIDE TABLET;ORAL EQ 10MG BASE No No AB 1981/11/20 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2011/07/26 SUPPL-77(补充) Approval Labeling
2010/12/06 SUPPL-76(补充) Approval Labeling
2008/11/25 SUPPL-75(补充) Approval Labeling
2002/12/16 SUPPL-71(补充) Approval Manufacturing (CMC)
2002/09/26 SUPPL-70(补充) Approval Manufacturing (CMC)
2002/04/19 SUPPL-69(补充) Approval Manufacturing (CMC)
2002/01/10 SUPPL-67(补充) Approval Manufacturing (CMC)
2001/11/28 SUPPL-68(补充) Approval Labeling
2001/08/22 SUPPL-65(补充) Approval Manufacturing (CMC)
2001/05/09 SUPPL-66(补充) Approval Manufacturing (CMC)
1999/06/15 SUPPL-63(补充) Approval Labeling
1999/06/15 SUPPL-62(补充) Approval Manufacturing (CMC)
1999/06/15 SUPPL-61(补充) Approval Manufacturing (CMC)
1999/05/05 SUPPL-60(补充) Approval Manufacturing (CMC)
1998/01/27 SUPPL-57(补充) Approval Manufacturing (CMC)
1997/10/21 SUPPL-59(补充) Approval Manufacturing (CMC)
1997/10/21 SUPPL-58(补充) Approval Manufacturing (CMC)
1997/10/21 SUPPL-56(补充) Approval Manufacturing (CMC)
1997/08/11 SUPPL-55(补充) Approval Manufacturing (CMC)
1997/08/11 SUPPL-54(补充) Approval Manufacturing (CMC)
1995/11/02 SUPPL-53(补充) Approval Manufacturing (CMC)
1994/01/24 SUPPL-52(补充) Approval Manufacturing (CMC)
1992/08/13 SUPPL-51(补充) Approval Labeling
1992/03/27 SUPPL-50(补充) Approval Manufacturing (CMC)
1992/03/27 SUPPL-47(补充) Approval Labeling
1992/03/27 SUPPL-46(补充) Approval Manufacturing (CMC)
1992/02/03 SUPPL-49(补充) Approval Manufacturing (CMC)
1989/09/15 SUPPL-44(补充) Approval Labeling
1988/11/02 SUPPL-43(补充) Approval Labeling
1988/01/21 SUPPL-40(补充) Approval Manufacturing (CMC)
1988/01/21 SUPPL-39(补充) Approval Manufacturing (CMC)
1988/01/21 SUPPL-38(补充) Approval Manufacturing (CMC)
1988/01/21 SUPPL-37(补充) Approval Manufacturing (CMC)
1987/01/20 SUPPL-33(补充) Approval Manufacturing (CMC)
1986/03/03 SUPPL-32(补充) Approval Manufacturing (CMC)
1986/01/17 SUPPL-30(补充) Approval Manufacturing (CMC)
1986/01/17 SUPPL-29(补充) Approval Manufacturing (CMC)
1986/01/17 SUPPL-28(补充) Approval Manufacturing (CMC)
1985/04/09 SUPPL-25(补充) Approval Manufacturing (CMC)
1984/04/30 SUPPL-24(补充) Approval Manufacturing (CMC)
1983/08/10 SUPPL-13(补充) Approval Manufacturing (CMC)
1983/08/01 SUPPL-16(补充) Approval Manufacturing (CMC)
1983/08/01 SUPPL-14(补充) Approval Manufacturing (CMC)
1983/02/25 SUPPL-5(补充) Approval Manufacturing (CMC)
1982/12/15 SUPPL-1(补充) Approval Manufacturing (CMC)
1982/10/29 SUPPL-12(补充) Approval Manufacturing (CMC)
1982/10/29 SUPPL-11(补充) Approval Manufacturing (CMC)
1982/10/29 SUPPL-10(补充) Approval Manufacturing (CMC)
1982/06/03 SUPPL-8(补充) Approval Manufacturing (CMC)
1982/06/03 SUPPL-6(补充) Approval Manufacturing (CMC)
1981/11/20 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:TRIFLUOPERAZINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
085788 001 ANDA TRIFLUOPERAZINE HYDROCHLORIDE TRIFLUOPERAZINE HYDROCHLORIDE TABLET;ORAL EQ 10MG BASE Prescription No No AB Approved Prior to Jan 1, 1982 SANDOZ
040209 004 ANDA TRIFLUOPERAZINE HYDROCHLORIDE TRIFLUOPERAZINE HYDROCHLORIDE TABLET;ORAL EQ 10MG BASE Prescription No Yes AB 1997/07/07 MYLAN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database